Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure
- PMID: 35318292
- DOI: 10.14309/ajg.0000000000001702
Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure
Comment on
-
Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.Am J Gastroenterol. 2022 Apr 1;117(4):607-616. doi: 10.14309/ajg.0000000000001611. Am J Gastroenterol. 2022. PMID: 35041634 Clinical Trial.
References
REFERENCE
-
- Kulkarni AV, Tirumalle S, Premkumar M, et al. Primary norfloxacin prophylaxis for APASL-defined acute-on-chronic liver failure: A placebo-controlled double-blind randomized trial. Am J Gastroenterol 2022;117(4):607–16.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources